Broadcom: High Quality And Undervalued AI Stock

Broadcom is presented as attractive at a 17.4x forward P/E based on projected fiscal 2028 earnings, supported by strong expected EPS growth and a record of beating earnings estimates. The analyst price target of $531.85 implies 49% upside, while upward revisions to earnings and growth forecasts reinforce the bullish outlook.

Analysis

The valuation argument is only durable if AVGO converts AI-custom-silicon demand into earnings growth without sacrificing the unusually high gross-margin profile of its semiconductor franchise. The key incremental debate is whether hyperscaler ASIC programs expand the total accelerator market or merely shift spend away from NVDA GPUs; AVGO can win in either case, but a larger ASIC mix would likely pressure its premium multiple if investors conclude revenue is more customer-concentrated and less recurring than software. Marvell (MRVL) is the closest public read-through competitor, while NVDA is the principal relative-value hedge against a faster-than-expected GPU-led AI capex cycle.

Over the next 1-3 months, estimate revisions and AI-networking/custom-silicon commentary matter more than a static multi-year price target. AVGO's software contribution provides downside ballast, but VMware execution is also the main multiple-risk variable: sustained customer churn, weak renewals, or slower synergy realization would expose the equity to a de-rating even if semiconductor earnings remain intact. Over 6-18 months, the upside case requires AI revenue growth to persist beyond initial hyperscaler deployments and for free-cash-flow conversion to validate that growth is not being purchased through rising working capital or customer concessions.

Consensus may be underestimating the strategic value of AVGO's position as the merchant supplier enabling hyperscalers to reduce dependence on NVDA, particularly where custom compute, switching, and optical connectivity are designed together. Conversely, the apparent forward multiple can be misleading if fiscal-2028 estimates embed both uninterrupted AI capex and full VMware margin normalization; the relevant risk is not a modest earnings miss, but a reset to the terminal growth rate embedded in outer-year estimates.

Key Decisions for Investors

• Initiate a 6-12 month long AVGO / short MRVL pair at roughly equal semiconductor beta. The trade expresses AVGO's superior software cash-flow cushion and broader AI-system exposure; exit if MRVL closes the AI revenue-growth gap for two consecutive quarters or AVGO guides to material ASIC pricing pressure.
• For directional exposure, buy AVGO on post-earnings volatility rather than ahead of the print; require confirmation that AI semiconductor growth and VMware operating margins are both tracking at or above management's prior trajectory. Target a 15-20% upside over 6-12 months versus an 8-10% stop tied to a downward revision in next-fiscal-year EPS consensus.
• Use NVDA as a hedge for an AVGO core long when hyperscaler capex data are ambiguous: long AVGO / short a smaller notional of NVDA limits exposure to a broad AI multiple compression while retaining the thesis that custom silicon and infrastructure attach rates gain share.
• Set an earnings watch item for VMware renewal/churn metrics, software operating-margin progression, and the concentration of AI revenue among top customers. A meaningful deterioration in any of these indicators would invalidate the low-multiple compounding thesis before headline EPS estimates visibly reset.